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RESEARCH ARTICLE
The connexin 30 A88V mutant reduces cochlear gap junction
expression and confers long-term protection against hearing loss
John J. Kelly, Julia M. Abitbol, Stephanie Hulme, Eric R. Press, Dale W. Laird* and Brian L. Allman*,‡
ABSTRACT
Mutations in the genes that encode the gap junction proteins
connexin 26 (Cx26, encoded by GJB2) and Cx30 (GJB6) are the
leading cause of hereditary hearing loss. That said, the Cx30
p.Ala88Val (A88V) mutant causes Clouston syndrome, but not
hearing loss. Here, we report that the Cx30-A88V mutant, despite
being toxic to inner ear-derived HEI-OC1 cells, conferred remarkable
long-term protection against age-related high frequency hearing loss
in Cx30A88V/A88V mice. During early development, there were no overt
structural differences in the cochlea between genotypes, including a
normal complement of hair cells; however, the supporting cell Cx30
gap junction plaques in mutant mice were reduced in size. In
adulthood, Cx30A88V/A88V mutant mice had a reduction of cochlear
Cx30 mRNA and protein, yet a full complement of hair cells.
Conversely, the age-related high frequency hearing loss in Cx30+/+
and Cx30+/A88V micewas due to extensive loss of outer hair cells. Our
data suggest that the Cx30-A88V mutant confers long-term hearing
protection and prevention of hair cell death, possibly via a feedback
mechanism that leads to the reduction of total Cx30 gap junction
expression in the cochlea.
KEYWORDS: Connexin, Gap junction, Hearing, Mouse, Cx30, GJB6,
Clouston syndrome, Aging
INTRODUCTION
Connexins (Cxs) are a large family (21 subtypes in humans) of
transmembrane proteins that oligomerize into hexameric structures
known as connexons.When trafficked to the cell surface, connexons
can function independently as ‘hemichannels’ or dock with a
compatible connexon on an adjacent cell to form direct cell–cell
communication channels called gap junctions (Laird, 2006; Sáez
and Leybaert, 2014). The Cx composition of gap junctions helps
regulate and direct the movement of ions and small metabolites
(Alexander and Goldberg, 2003; Neijssen et al., 2005) between
cells, or in the case of hemichannels, between cells and the external
milieu (Anselmi et al., 2008). Therefore, gap junctions and
hemichannels are proposed to have roles in several processes such
as cell signalling, tissue development, potassium buffering and
intercellular biochemical coupling for coordination of tissue
responses such as wound healing, to name just a few. It is now
apparent that almost all tissues in the human body require some
degree of gap junctional intercellular communication (GJIC), as
evidenced by over two dozen distinct diseases associated with
connexin gene mutations (Kelly et al., 2015). GJIC is aided by the
accumulation of hundreds to thousands of gap junction channels
into large plaque-like regions between cells. In particular, the non-
sensory cells of the cochlea express some of the largest gap junction
plaques in mammals and are extensively coupled by two gap
junction networks, the epithelial and connective tissue gap junction
networks (Forge et al., 2003b; Kikuchi et al., 1995). Connexin 26
(Cx26, encoded by GJB2) and Cx30 (GJB6) are the main Cx
subtypes found within both gap junction networks of the cochlea
where they can assemble into mixed heteromeric or heterotypic
channels (Ahmad et al., 2003; Forge et al., 2003a; Lautermann
et al., 1998). The importance of Cx26 and Cx30 to hearing and
cochlear homeostasis is highlighted by the fact that mutations in the
genes that encode Cx26 (GJB2) and Cx30 (GJB6) in humans are
the most common cause of inherited non-syndromic pre-lingual
deafness (Chan and Chang, 2014; Kenneson et al., 2002; Snoeckx
et al., 2005). In these instances, hearing loss is the only phenotypic
outcome of the mutation; however, other tissues also express Cx26
and Cx30, such as the skin and glial networks in the brain.
Depending on the type of mutation in the GJB2 or GJB6 genes,
other comorbidities such as skin disease may (syndromic) or
may not (non-syndromic) occur with hearing loss, such as the
rare autosomal dominant disorder Clouston syndrome (OMIM
#129500).
Clouston syndrome, also known as hidrotic ectodermal dysplasia,
is characterized by thin, wiry hair, alopecia, thickening and
hyperpigmentation of the skin and dystrophy of the nails (Fraser
and Der Kaloustian, 2001; Lamartine et al., 2000). Currently, at
least four missense mutations causing amino acid substitutions
G11R, V37E, D50N and A88V in the Cx30 polypeptide chain are
associated with Clouston syndrome (Baris et al., 2008; Chen et al.,
2010; Jan et al., 2004; Smith et al., 2002; Zhang et al., 2003).
In most instances, hearing loss is not associated with Clouston
syndrome, and only appears in patients with double heterozygosity
for mutations in both the Cx26 and Cx30 genes (Jan et al., 2004;
Sugiura et al., 2013). This preservation of hearing in Clouston
syndrome patients harbouring only the GJB6 mutation encoding
Cx30-A88V is intriguing given that our previous in vitro studies
found that expressing the Cx30-A88V mutant alone in both HeLa
cells and rat epidermal keratinocytes (REK cells) induced potent
activation of cleaved caspase 3 and consequent cell death (Berger
et al., 2014). Based on these results, we postulated that the Cx30-
A88V mutant leads to a loss of channel control and ‘leaky’
hemichannels either from within intracellular compartments or at
the cell surface, the latter of which has also been reported by
others (Essenfelder et al., 2004). Although these in vitro studies
showed that the Cx30-A88V mutant can be highly toxic when
overexpressed in certain cell lines, it is unclear if this toxicity is
cell-type specific, raising the possibility that cochlear cells are
more resistant to the effects of the Cx30-A88V mutant.Received 17 August 2018; Accepted 6 December 2018
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To elucidate the mechanisms by which the Cx30-A88V mutant
causes Clouston syndrome, Bosen and colleagues created a mouse
model of the disease on a CD-1 mouse background (Bosen et al.,
2014). These Cx30-A88V mutant mice exhibited hyperproliferative
and enlarged sebaceous glands, and mild palmoplantar
hyperkeratosis (Bosen et al., 2014), as well as an unusual hearing
profile compared to wild-type mice that was characterized by poorer
(elevated) hearing thresholds within the lower frequency ranges in
the apical region of the cochlea (<10 kHz), but substantially
improved hearing within the high frequency, basal region of the
cochlea (Bosen et al., 2014; Lukashkina et al., 2017). This hearing
profile is particularly interesting given that CD-1 mice usually
suffer from an inherent early-onset, progressive hearing loss
(Mahendrasingam et al., 2011). At present, however, it remains
unknown whether the Cx30-A88V mutant confers long-term
protection to high frequency hearing during aging, because the
aforementioned studies on Cx30-A88V mutants were restricted to
assessing young adult mice between 3 and 9 weeks of age (Bosen
et al., 2014; Lukashkina et al., 2017). Moreover, although the skin
of Cx30-A88V mutant mice showed similar Cx30 expression levels
to that of wild-type mice (Bosen et al., 2014), no prior studies have
investigated whether the expression levels of Cx30 – and possible
influence on Cx26 – differ in the cochleae of mutant mice, or how
the Cx30-A88V mutant affects the sensorineural and supporting
cells during aging.
In the present study, we used a combination of in vitro and in vivo
techniques to determine the effect of the Cx30-A88V mutant on
age-related changes in the structure and function of the mouse
cochlea. First, to investigate the potential for cell-specific toxicity
caused by the Cx30-A88V mutant, we overexpressed it in an inner
ear cell line (House Ear Institute-Organ of Corti, HEI-OC1 cells)
derived from the Immortomouse (Kalinec et al., 2016) that would
normally express Cx30 in vivo. Next, we harvested the cochleae
from neonatal mutant and wild-type mice, and prepared organotypic
cultures that were immunolabelled to reveal Cx30-A88V mutant-
related changes in gap junction morphology, including Cx30 plaque
density and size. Ultimately, to determine whether the unusual
hearing profile previously reported in Cx30-A88V mutant mice
(Bosen et al., 2014; Lukashkina et al., 2017) exhibited long-term
protection against hearing loss, we assessed the hearing thresholds
in the mutant versus wild-type mice at both 3 and 6 months of age.
At these same aging time points, adult mice were euthanized and
cochlear cryosections were immunolabelled to assess the gross
morphology and gene expression profile of the cochlear lateral wall.
Finally, to determine whether the Cx30-A88V mutant protected
against the age-related death of sensorineural cells in mice on the
CD-1 background, we immunolabelled cochlear cryosections
and whole mounts of 3- and 6-month-old Cx30-A88V mutant and
wild-type mice for markers of sensory hair cells and spiral ganglion
neurons. Taken together, the results of this study provide an
improved understanding of the important and complex role Cx30
plays in the structure and function of cochlear cells across
the lifespan.
RESULTS
The Cx30-A88V mutant is cytotoxic to HEI-OC1 cells
Our lab and others have shown that the Cx30-A88V mutant is
cytotoxic when overexpressed in HeLa and REK cell lines, and that
co-expression of Cx26 is unable to rescue this effect (Berger et al.,
2014; Essenfelder et al., 2004; Lu et al., 2018). To determine
whether cochlear cells, which would normally express Cx30 in vivo,
are particularly resistant to the cytotoxic effects of the mutant, Cx30
(wild-type) and Cx30-A88V, in addition to C-terminal GFP-tagged
variants, were overexpressed in an inner ear cell line (HEI-OC1).
Cells expressing Cx30 or Cx30–GFP appeared healthy and formed
normal gap junction plaques between Cx30-expressing cells
(Fig. 1). However, in a similar fashion to our previous in vitro
studies (Berger et al., 2014), both the untagged and GFP-tagged
Cx30-A88V mutants were cytotoxic, as evidenced by pyknotic
nuclei and a shrunken cytoplasm (Fig. 1). There was also a distinct
lack of gap junction plaques between cells expressing mutant
Cx30-A88V, indicating that HEI-OC1 cells are also susceptible to
Cx30-A88V-induced cytotoxicity, as seen previously in HeLa,
REK and HaCaT cells (Berger et al., 2014; Essenfelder et al., 2004;
Lu et al., 2018). To further elucidate the subcellular localization of
the Cx30-A88V mutant in the limited number of cells that survived,
we immunostained for markers of intracellular compartments and
found that a substantial amount of Cx30-A88V co-localized with
GM130, a marker for the Golgi apparatus (Fig. S1).
Cx30-A88V mutant mice exhibit prolonged protection
against hearing loss in CD-1 mice
Since the Cx30-A88V mutant was found to be toxic in vitro, it was
somewhat surprising that a mouse model expressing the mutant did
not exhibit pronounced hearing loss (Bosen et al., 2014). In fact, mice
expressing the mutant showed better hearing profiles than their wild-
type and heterozygote littermate controls at 6–9 weeks of age (Bosen
et al., 2014). In the present study, we sought to extend this finding
and determine whether the mutant also confers long-term protection
against hearing loss in aging mutant mice by assessing their hearing
profiles. To do so, we used the auditory brainstem response (ABR),
which is a measure of the electrical activity in the brainstem evoked
by the repeated presentation of a given acoustic stimulus. Initially,
the hearing profiles of all genotypes in the first week after weaning
(3–4 weeks old) showed no significant difference in their ability to
detect broadband noise (click stimuli, Fig. 2A). Paradoxically, the
hearing thresholds at low frequencies (4 and 8 kHz) were
significantly higher in homozygous (Cx30A88V/A88V) mice
compared to wild-type (Cx30+/+) and heterozygous (Cx30+/A88V)
littermate controls (indicative of worsened hearing in homozygous
mutant mice), whereas those at the higher frequencies (24 and
32 kHz) were significantly lower (indicative of better hearing)
(Fig. 2A). At 3 months of age, wild-type mice showed progressive
high-to-low frequency hearing loss, whereas homozygous mice
showed significantly better hearing at the click stimulus and at 16, 24
and 32 kHz (Fig. 2A). Even at 6 months of age, homozygous mice
showed significantly better hearing thresholds at the click, 16, 24 and
32 kHz stimuli (Fig. 2A). Interestingly, a comparison of one wild-
type and one homozygote mutant mouse at 1 year of age (shown as
grey shaded lines in the 6 months graph) revealed extended hearing
protection in the homozygote. Owing to a lack of mice at this age,
these data represent single mouse ABR profiles and were not used for
any statistical analysis.
To assess the neural output transmitted along the auditory nerve
exiting the cochlea, we next determined the latency (Fig. 2B, in ms)
and amplitude (Fig. 2C, in µV) of the peak of the first wave of the
ABR (wave I) in response to the 90 dB sound pressure level (SPL)
click stimulus. These measurements give a general indication of the
number and integrity of neurons firing (measured by the amplitude)
as well as the conduction speed of those neurons (measured by the
latency from stimulus onset to wave I) after hair cell activation.
Representative ABR traces of the amplitudes and latencies of all
three genotypes are shown in Fig. S2. At 3 and 6 months of age,
homozygous mutant mice displayed significantly faster wave I
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latencies compared to wild-type mice (Fig. 2B) and significantly
higher wave I amplitudes across all age sets (Fig. 2C), indicating an
overall better neural output from the cochlea. It is important to note
that although the homozygous mutant mice showed significantly
elevated amplitudes at 6 months of age, they still exhibited an∼26%
age-related decline in neural output at 6 months compared to
young mice. However, this pales in comparison to wild-type and
heterozygous mice, which had ∼66% and ∼64% age-related
reductions in wave I amplitude, respectively. These data indicate
that even though there is a slight decline in the hearing profile of
homozygous mutant mice with age, they exhibit remarkable,
prolonged hearing protection on a mouse background that
normally presents with early-onset hearing loss.
Wild-type and mutant mice exhibit normal cochlear
development, but reduced Cx30 gap junction plaques in
homozygous mice
We next investigated whether there were any differences in the
cochlear epithelium and/or hair cell development, as well as Cx30
expression, between the three genotypes at early postnatal ages.
Whole cochlear sensory epithelia cultured for 24 h showed normal
organ of Corti structure (three rows of outer hair cells and one row
of inner hair cells) in both the basal (high frequency) and apical
(low frequency) regions of the epithelium (Fig. 3A). At lower
magnification, there appeared to be a reduced density of Cx30 gap
junction plaques in the homozygous mice in the basal region of the
epithelium (Fig. 3A). To investigate this further, same thickness
(∼30 µm), high-resolution Airyscan image stacks of Cx30 (green)
in basal and apical regions were flattened (Fig. 3B) and magnified
(insets, Fig. 3B). Interestingly, the density and size of Cx30 gap
junction plaques was reduced in both basal and apical regions of
homozygous epithelia, with the difference being more pronounced
in the high frequency basal turn regions.
Next, using cochlear cryosections immunostained for Cx30
(green) and counterstained with phalloidin (red) and DAPI (blue) to
label actin and nuclei, respectively, we saw no overt differences
in the cochlear duct structure in either the basal or apical turns
across the genotypes of 3-month-old mice (Fig. 4A). In addition,
although the localization of Cx30 did not seem to differ across
genotypes, there was an apparent reduction in Cx30 intensity in the
type II fibrocyte region of the cochlear lateral wall within the basal
turn of homozygous mutant mice (asterisk, Fig. 4A).
To determine whether the reduced endocochlear potential (EP)
reported by Lukashkina et al. (2017) in homozygous mice was due
to gross malformations in the stria vascularis, we immunostained
cryosections for Kir4.1 (green), an intermediate cell-specific
potassium channel that is essential for the EP, and counterstained
for actin (red) that demarcates the strial unit (Fig. 4B). We found no
obvious differences in the structure of the stria vascularis or
expression levels of Kir4.1 across genotypes or cochlear turns
Fig. 1. Cx30-A88V is toxic to HEI-OC-1 cells. (A) HEI-OC1
cells engineered to transiently express untagged or GFP-
tagged wild-type Cx30 or the Cx30-A88V mutant (green) were
counterstained with Hoechst 33342 (blue) to label nuclei.
Cells expressing Cx30 or Cx30–GFP showed normal cell
morphology and Cx30 localization to gap junction-like puncta
at cell–cell interfaces (thin arrows). Nuclei appeared normal
and healthy. (B) In contrast, Cx30-A88VandCx30-A88V–GFP
expressing cells exhibited shrunken cell bodies, a lack of gap
junction-like puncta and condensed, pyknotic nuclei (thick
arrows), suggesting that the cells expressing the Cx30-A88V
mutant were undergoing cell death. Scale bars: 10 µm.
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(Fig. 4B), indicating that the structure of the stria vascularis and
expression of Kir4.1 is not disrupted in homozygous mutant mice.
Cx30 mRNA and protein is reduced in Cx30-A88V
mutant cochleae
Modifications of the Cx30 gene,Gjb6, have been shown to not only
influence the mRNA and protein levels of Cx30, but also of Cx26
(Boulay et al., 2013; Ortolano et al., 2008; Schütz et al., 2010).
Therefore, we investigated whether the Cx30-A88V gene mutation
affected the levels of Cx30 and Cx26 mRNA and protein in whole
cochleae extracts. In mice at 4–6 weeks of age, there was a
significant decrease in Cx30 mRNA (homozygotes only) and
protein levels (heterozygotes and homozygotes) compared to
littermate wild-type controls (Fig. 5A,B), but no significant
reduction in Cx26 mRNA or protein (Fig. 5A,B). In a similar
fashion, in mice at 3 months of age, there were significant
reductions in mRNA (homozygotes only) and protein
(heterozygotes and homozygotes) for Cx30, but not for Cx26,
compared to wild-types (Fig. 6A,B). These data indicate that the
Cx30-A88V genetic mutation leads to a downregulation or loss
of stability of Cx30 mRNA and/or protein in homozygous mouse
cochleae.
A88V mutant mice are protected against hair cell loss
We next determined whether the hearing loss seen in CD-1 wild-
type and heterozygote mice is due to hair cell and/or spiral ganglion
neural projection loss in adult and aged animals. Z-stack orthogonal
projections from cochlear cryosections of 3-month-old mice
revealed an absence of outer hair cells in the basal turn of wild-
type and heterozygote mice, but not in the apical turns (Fig. 7A);
Fig. 2. Aged Cx30A88V/A88V mice are protected against hearing loss. (A) Broadband (click) and frequency-specific ABR profiles of young (3–4 weeks)
and aged (3 and 6 months) Cx30+/+, Cx30+/A88V and Cx30A88V/A88V CD-1 mice revealed a dramatic early-onset, high frequency hearing loss in Cx30+/+ and
Cx30+/A88V mice that was protected against in Cx30A88V/A88V mice. ABR data from single 1-year-old Cx30+/+ and Cx30A88V/A88V mice (plotted in grey on the
6month chart) showed hearing protection in the homozygousmutant even at this advanced age. (B) Latenciesmeasured from the onset of the click stimulus to the
peak of wave I at 90 dB SPL show improved neural conduction speeds (shorter latencies) in Cx30A88V/A88V mice at 3 and 6 months of age. (C) Wave I click
amplitudes at 90 dB SPL also showed consistently higher neural firing/synchrony in Cx30A88V/A88V mice across all age groups, although the average amplitude
across all genotypes did decrease with age. *P<0.05, **P<0.01, ***P<0.001 by two-way ANOVA (A) or one-way ANOVA (B,C). N=6 mice per each genotype for
each age set. Error bars represent s.e.m.
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findings consistent with the high frequency hearing loss profile
observed in these genotypes. In contrast, homozygous Cx30-A88V
mice had a normal complement of three rows of outer hair cells and
one row of inner hair cells in both basal and apical turns (Fig. 7A). In
addition, type II neural projections to the outer hair cells were visible
crossing Nuel’s space in the basal turn of homozygous mice (arrow,
Fig. 7A), which were absent in the basal turns of wild-type and
heterozygote mice. Conversely, there were no apparent deficits in
the apical turn across all mouse genotypes.
Consistent with the loss of outer hair cells at 3 months of age,
whole-mount cochlear epithelia from 6-month-old mice also
showed severe loss of outer hair cells and reduced density of
inner hair cells in wild-type and heterozygous mice, as determined
by actin (phalloidin) and nuclei (DAPI) staining (Fig. 7B). Even at
6 months of age, homozygous mutant mice showed remarkable
persistence of inner and outer hair cells in the basal turn, with only a
few outer hair cells missing (Fig. 7B). The structure of the
epithelium was largely maintained across genotypes in the apical
turns. These data indicate that severe hearing loss seen in wild-type
and heterozygous Cx30-A88V CD-1 mice was due to a fast
progression of hair cell loss in a basal to apical gradient, whereas
homozygous mutant mice were protected against hair cell loss.
Fig. 3. Organotypic cultures exhibit reduced gap junction expression in neonatal Cx30A88V/A88V mice. (A) Representative full thickness z-stack
projections of organotypic cultures from 3–4-day-oldmouse pupswere immunolabelled for Cx26 (red), Cx30 (green) and counterstainedwith fluorescently tagged
phalloidin to demarcate hair cells (white) in basal and apical turns of the cochlear epithelium. There was a normal complement of three rows of outer hair
cells (OHCs) and one row of inner hair cells (IHCs) across all genotypes. Scale bars: 20 µm. (B) Same thickness (30 µm), high-resolution Airyscan z-stack
projections of Cx30 (green) in Kölliker’s organ cells showed a consistent decrease in Cx30 plaque density and plaque size in mutant mice. The positions of hair
cell rows are marked by the outlined rectangles. Insets represent magnified images within dashed boxes. Scale bars: 10 µm.
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DISCUSSION
Mutations in the genes that encode Cx26 and Cx30 are most
commonly linked to hereditary hearing loss and skin disease,
indicating a vital role for these Cxs in normal cochlear and skin
physiology (Xu and Nicholson, 2013). Although the Cx30-A88V
mutant causes an ectodermal dysplasia known as Clouston
syndrome, it has not been reported to cause hearing loss when
patients have a normal complement of Cx26 (Jan et al., 2004;
Sugiura et al., 2013). This is surprising for two reasons: (1) we and
others have shown that the Cx30-A88V mutant is highly toxic to
cells when overexpressed in an in vitro system (Berger et al., 2014;
Essenfelder et al., 2004; Lu et al., 2018), and (2) Cx30 is highly
abundant in the inner ear (Ahmad et al., 2003; Forge et al., 2003b;
Kikuchi et al., 1995; Lautermann et al., 1998), which suggests that
any perturbations in its normal function could have negative
consequences in the exquisitely sensitive sensory epithelium
(Johnson et al., 2017; Sun et al., 2005; Zhang et al., 2005). In the
present study, we aimed to provide an improved understanding of
the role Cx30 plays in supporting the cochlear cells that are essential
for hearing across a normal lifespan. To that end, we conducted a
novel investigation into the effect of the Cx30-A88V mutant on
age-related changes in the structure and function of the cochlea
using in vitro and in vivo mouse models.
In our first experimental series, we overexpressed the Cx30-
A88V mutant in HEI-OC1 cells to determine whether it would
trigger cell death in a hearing-relevant cell line, or alternatively,
whether cochlear cells would be resistant to Cx30-A88V-related
toxicity. Similar to what we had observed in HeLa and REK cells,
the Cx30-A88V mutant drove HEI-OC1 cells into a cell death
pathway, possibly due to the overproduction of ‘leaky’
hemichannels; findings which have been observed previously for
this mutant (Essenfelder et al., 2004) as well as for other Cx skin
Fig. 4. Cochlear cryosections reveal
normal gross anatomy, but reduced Cx30
expression in the lateral wall of 3-month-old
mice. (A) Cryosections (18 µm thickness)
were immunostained for Cx30 (green) and
counterstained with fluorescently tagged
phalloidin to label actin (red) and Hoechst
33342 to label nuclei (blue). Representative
images of basal and apical turns for all three
genotypes are shown. The structure of all the
three cochleae from each genotype appeared
similar; however, there was a noticeable
reduction of Cx30 labelling in fibrocytes
resident in the basal turn of the Cx30A88V/A88V
lateral wall (asterisk). Scale bars: 50 µm.
(B) Cryosections were immunolabelled for
Kir4.1 (green), a marker of strial intermediate
cells, and counterstained for actin (red, which
demarcates strial basal cells) and nuclei (blue).
Representative images of the stria vascularis in
all turns of the cochlea showed no obvious
differences inmorphology or Kir4.1 expression.
Scale bars: 20 µm.
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disease-linked mutants (Chi et al., 2012; García et al., 2015;Mhaske
et al., 2013; Retamal et al., 2015). It is worth noting that, despite the
toxic effects observed in vitro, keratinocytes from homozygous
mutant mice appeared healthy, and the skin of these mice exhibited
only mild palmoplantar hyperkeratosis (Bosen et al., 2014). These
findings strongly argue for studying Cx-linked mutants in mouse
models because the dosage of the mutant expressed can
dramatically affect the cell phenotype. In this case, the mutant
mouse expresses the appropriate levels of the Cx30-A88V mutant
given that the endogenous Cx30 promoter remains fully intact,
whereas overexpression of the Cx30-A88V mutant presumably
drives the toxicity seen in cell lines. Importantly, potential crosstalk
between Cx30 mutant expression and its closely related isoform,
Cx26, can be investigated in an in vivo setting that would mimic the
clinical context.
To determine the effect of the Cx30-A88V mutant in vivo, we
examined Cx30 distribution by immunolabelling the cochleae of
neonatal mice, and we also assessed the mRNA and protein levels of
Cx30 and Cx26 in whole cochleae extracts from adult mice. Unlike
the skin of Cx30-A88V mutant mice, which showed similar Cx30
expression levels to that of wild-type mice (Bosen et al., 2014), in
the present study we observed a reduction in the density and size of
Cx30 gap junction plaques in cochleae of homozygous mutant
mice. It is reasonable to predict that these gap junctions, while
present, are likely to be non-functional because the Cx30-A88V
mutant has been shown to be incapable of forming functional gap
junction channels (Berger et al., 2014). Overall, the altered gap
junction morphology in the Cx30-A88V mutant mice corresponded
with a reduction in total Cx30 mRNA and protein in the
homozygous mutant mice, suggesting that the mutation was
destabilizing the Cx30 mRNA, resulting in overall lower Cx30
production.
Previous studies have reported an unusual hearing profile in
young adult mice (3–9 weeks old) expressing the homozygous
Cx30-A88V mutant (Bosen et al., 2014; Lukashkina et al., 2017),
whereby they were protected from the early-onset, high frequency
hearing loss inherent to wild-type mice on the CD-1 background.
Furthermore, homozygous Cx30-A88V mutant mice had a greatly
reduced level of cochlear amplification linked to their outer hair
cells (Bosen et al., 2014; Lukashkina et al., 2017); findings which at
first may seem inconsistent with the preserved hearing thresholds in
these mutants, yet ultimately suggestive of a role for Cx30 gap
junctions in sensory processing. However, it remained unclear
whether other mechanisms contributed to the preservation of high
frequency hearing in young mutant mice, such as compensatory Cx
expression, or whether aging mutant mice would eventually revert
to similar hearing loss levels as those found in wild-type or
heterozygous mice. In addressing these issues in the present study,
we confirmed the previously-reported hearing preservation in
young homozygous mutant mice (Bosen et al., 2014; Lukashkina
Fig. 5. Four-to-six-week-old Cx30A88V/A88V mice
exhibit reduced Cx30 mRNA and protein levels.
(A) Cx26 and Cx30 mRNA expression levels were
quantified using qPCR and normalized to 18S rRNA.
There was a significant reduction of Cx30 mRNA in
Cx30A88V/A88V mice compared to Cx30+/+. N=3, *P<0.05.
(B) Western blot analysis showed a reduction of Cx30
protein levels in Cx30+/A88V and Cx30A88V/A88V cochleae
in comparison to wild-type littermate controls (Cx30+/+).
N=3, **P<0.01, ***P<0.001. Error bars represent s.e.m.
A wild-type sample was set as a control.
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et al., 2017), and we have shown for the first time that the Cx30-
A88V mutant confers long-term protection to high frequency
hearing in aged mice (6 months old), with evidence of hearing
protection even at 1 year old. Furthermore, given that the
homozygous Cx30-A88V mutant mice in the present study
maintained nearly a full complement of outer hair cells in older
age as well as preserved ABR wave I amplitudes and latencies, and
young mutants showed greater cochlear sensitivity (as revealed by
their distortion product otoacoustic emissions) (Bosen et al., 2014;
Lukashkina et al., 2017) than their wild-type littermates, it is
reasonable to predict that higher-level auditory processing may also
be preserved in the aged mutants. For example, unlike wild-type
mice on the CD-1 background, Cx30-A88V mutant mice could be
expected to show awell-preserved sensitivity to the spectrotemporal
features of sound in their environment, including accurate frequency
discrimination and temporal processing (e.g. gap detection);
features known to be impaired following outer hair cell loss and/
or damage (Oxenham and Bacon, 2003). That said, future studies
would be needed to determine whether such higher-level auditory
processing is indeed spared in the homozygous mutant mice
because Cx30 is also expressed in astrocytes throughout the central
auditory pathway (Nagy et al., 1999).
At present, the reason(s) for the preservation of hearing in
the aged homozygous Cx30-A88V mutant mice is unclear. On
first thought, one might argue that a loss or dramatic reduction of
Cx30-A88V function would prevent the passage of small cellular
signals that might ultimately contribute to the hair cell death we
observed in the wild-type mice. However, this explanation is not
likely to be sufficient, given that the hair cells are isolated from
the gap junctional networks found in the organ of Corti, and should
not directly receive any cell death signals that might pass through
a gap junction. A second explanation may involve hyperactive
Cx30-A88V hemichannels, as shown previously in HeLa cells
(Essenfelder et al., 2004), that release ATP or other small molecules
from the supporting cells of the organ of Corti to the extracellular
milieu. That said, this process would be expected to lead to
supporting cell death, and ultimately to a general deterioration in
integrity of the organ of Corti; findings that were not observed even
in aged mutant mice. In fact, both the inner and outer hair cells in the
organ of Corti of the homozygous Cx30-A88V mutants were found
to be healthy, in contrast to the extensive cell loss seen in wild-type
mice. A third possibility rests on the prospect of a Cx feedback
system where the loss of Cx30 function and protein level would
dramatically drive the increased expression and stability of the
closely related Cx26, as this level of regulation in the cochlea has
been previously reported (Boulay et al., 2013; Ortolano et al., 2008).
However, in both young and aged heterozygous or homozygous
mutant mice this was not the case as Cx26 mRNA and protein levels
remained unchanged, although the functional activity of Cx26 was
not directly examined. Finally, because the Cx30-A88V mutant has
Fig. 6. Three-month-old Cx30A88V/A88V mice have
reduced Cx30 mRNA and protein levels. (A) Cx26
and Cx30 mRNA expression levels of were quantified
using qPCR and normalized to 18S rRNA. There was a
significant reduction of Cx30 mRNA in Cx30A88V/A88V
mice compared to Cx30+/+.N=4, **P<0.01. (B)Western
blot analysis showed a consistent reduction of Cx30
protein levels in Cx30+/A88V and Cx30A88V/A88V
cochleae in comparison to wild-type littermate controls
(Cx30+/+). N=4, *P<0.05, ***P<0.001. Error bars
represent s.e.m.
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been linked to cytotoxicity, one might speculate that the reduced
levels of Cx30 mRNA and protein may represent a negative
feedback loop whereby the cells protect themselves against cell
death by downregulating toxic signals from entering or
disseminating amongst supporting cells. In support of this notion,
reducing functional Cx30 levels in the cochlea can be well tolerated
as we know that Gjb6 gene-ablated mice hear normally (Boulay
et al., 2013).
The discovery that homozygous Cx30-A88V mice exhibit better
high frequency hearing than wild-type mice on the shared CD-1
background is all the more remarkable since the mutant mice also
exhibit a reduced EP (Lukashkina et al., 2017) – the positive
potential in the endolymphatic space (+80 to 100 mV) that is created
by the stria vascularis, and is thought to be essential for hair
cell transduction and hearing sensitivity (Nin et al., 2008).
In considering the Cx30-A88V-related reduction in the EP,
Lukashkina and colleagues proposed a novel mechanism that
may contribute to the preserved hearing sensitivity observed in
these Cx30-A88V mutant mice (Lukashkina et al., 2017). It was
suggested that the electromotility of the outer hair cells – a crucial
feature for hearing sensitivity – could be driven by extracellular
potentials in their vicinity, instead of solely by current flux through
their mechanotransducer channels. It was presumed that this
alternative method of facilitating outer hair cell electromotility
was possible thanks to an accumulation of cations and,
consequently, extracellular potentials, that resulted from a
Cx30-A88V mutation-related impairment in the electrical
coupling through gap junctions in the sensory epithelium.
Ultimately, the reduced expression of Cx30 that we observed in
the Cx30-A88V mutant mice in the present study provides some
support for the aforementioned hypothesis by Lukashkina and
colleagues (2017).
Fig. 7. Aged Cx30A88V/A88V mice
are protected against neuronal
and hair cell loss. (A) Cochlear
cryosections from 3-month-old mice
were immunolabelled for myosin-VI to
highlight hair cells (green) and
neurofilament to label neurons (red),
and counterstained with Hoechst
33342 to label nuclei (blue). The basal
turns of Cx30+/+ and Cx30+/A88V mice
lacked outer hair cells, whereas
Cx30A88V/A88Vmice had preserved hair
cells and neural projections crossing
Nuel’s space to outer hair cells (arrow).
Apical turns appeared similar between
genotypes. Scale bars: 20 µm.
(B) Z-stack projections from cochlear
whole-mounts from 6-month-old
mice. Hair cells were labelled with
fluorescently tagged phalloidin (red)
and counterstained with Hoechst
33342 to label nuclei (blue). There was
extensive loss of outer hair cells in the
basal turns of Cx30+/+ and Cx30+/A88V
mice, as evidenced by the lack of
V-shaped stereocilia bundles on the
apical surface and nuclei in the
baso-lateral region of hair cells. In
contrast, almost all basal turn outer
hair cells in Cx30A88V/A88V mice had
normal stereocilia bundles and nuclei.
Scale bars: 10 µm.
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To address the unresolved issue of how the Cx30-A88V mutant
may indeed be causing a reduction in the EP in mutant mice, we
immunolabelled cochlear cryosections and assessed the gross
morphology of the cochlear lateral wall, as well as the expression
of Kir4.1, an inwardly rectifying potassium channel found in the
apical membrane of intermediate cells in the stria vascularis that is
believed to be essential for EP development and maintenance
(Chen and Zhao, 2014; Marcus et al., 2002). Surprisingly, we found
no obvious differences in the morphology of the cochlear lateral
wall, including the stria vascularis, between the three genotypes.
Moreover, contrary to our prediction, there did not appear to be a
reduced expression of Kir4.1 in the mutant mice that could account
for the reduced EP reported previously (Lukashkina et al., 2017).
Because several Cx26 and/or Cx30 mutant mouse models also
exhibit reduced or absent EPs (Cohen-Salmon et al., 2002; Schutz
et al., 2011; Teubner et al., 2003), it will be of considerable interest
for future studies to further investigate the underlying cellular
mechanism(s) by which these Cxs influence the EP.
Intriguingly, there are no reports of Clouston syndrome patients
suffering from hearing loss, suggesting that a single allele encoding
the Cx30-A88V mutant in this autosomal dominant disease can
manifest as skin disease with no effect on hearing. Patients have not
been identified that have two alleles that encode the Cx30-A88V
mutant, but if they existed, the mouse studies suggest that they
would be protected from age-related hearing loss. That said, it is
highly debatable whether one copy would be sufficient to prevent
hearing loss in old age.
In conclusion, this study has shown for the first time that the
40–60 dB SPL high frequency hearing protection seen in young
adult Cx30-A88V mice is remarkably persistent in aged animals,
and therefore does not just represent a delay in hearing loss. We
suggest that the protection is conferred by the mutation causing an
overall reduction in Cx30, but not Cx26, RNA and protein levels
within the cochlea. Importantly, this leads to protection against hair
cell and neuronal death in mutant mice. The mechanism of this
protection, however, remains to be determined. It would also be
intriguing to seewhether Clouston syndrome patients expressing the
Cx30-A88V mutant exhibit better than normal hearing thresholds
during aging. Ultimately, our collective results suggest that
targeting the downregulation of Cx30 in the cochlea might be a
therapeutic option for the prevention of age-related hearing loss.
MATERIALS AND METHODS
Cell culture and constructs
HEI-OC1 cells (kindly provided byDr FedericoKalinec, Department ofHead
and Neck Surgery, David Geffen School of Medicine, UCLA, USA) were
cultured under permissive conditions (33°C and 10% CO2) in Dulbecco’s
Modified Eagle’s medium (DMEM; Sigma-Aldrich), containing 10% fetal
bovine serum (FBS; Thermo Fisher) without antibiotics. Mouse Cx30
wild-type and Cx30-A88V cDNA constructs with and without eGFP were
made as previously described (Berger et al., 2014). The Cx30 constructs were
transfected into HEI-OC1 cells using TransIT-LT1 (Mirus) transfection
reagent (1.5 µg DNA: 3 µl reagent in 6-well plates) for ∼18 h. Cells were
fixed in 4% paraformaldehyde (PFA) for 15 min at room temperature then
blocked and permeabilized in 3% bovine serum albumin (BSA) and 0.1%
Triton X-100. Cells expressing Cx30 without eGFP were then incubated
overnight at 4°C in rabbit anti-Cx30 antibody (1:400; Thermo Fisher, 71-
2200) and mouse anti-GM130 (1:500; BD Transduction Laboratories,
610822). Coverslips were then washed and incubated with anti-rabbit Alexa
Fluor 488 (1:500; Thermo Fisher, A11008) and anti-mouse Alexa Fluor 555
(1:500, Thermo Fisher, A32727) secondary antibodies for 1 h. All coverslips
were counterstained with the nuclear marker Hoechst 33342 and mounted in
ProLong Gold Antifade Mountant (Thermo Fisher, P36934). Confocal
images were acquired using a LSM800 Zeiss confocal microscope.
Mice
Cx30+/A88V and Cx30A88V/A88Vmicewere generated as previously described
(Bosen et al., 2014) and generously provided by Dr KlausWillecke (Life and
Medical Sciences Institute, Bonn, Germany). Mice were crossed several
times with CD-1 mice to generate a CD-1 background of ∼88%. Genotypes
of wild-type, Cx30+/A88V andCx30A88V/A88Vmicewere confirmed bymeans
of gel electrophoresis of PCR products using the following primers: forward,
5′-GGTCGAAGGAACCTTTCACAGG-3′ and reverse, 5′-GCTACCATC-
ACGTGCTCTTTGG-3′, which give rise to bands of 423 bp (wild-type) and
481 bp (A88V). Male mice used in this study were housed in the animal care
facilities at the University of Western Ontario and maintained on a 12 h/12 h
dark/light cycle with food and water provided ad libitum. All experiments
were approved by the Animal Care Committee at the University of Western
Ontario.
Hearing assessmentwith theauditory brainstem response (ABR)
Hearing levels were assessed using the ABR technique, which measures
the electrical activity in the brainstem evoked by the repeated presentation
of a given acoustic stimulus. Five different acoustic stimuli were used for
this study, including a broadband click stimulus, and 8, 16, 24 and 32 kHz
tonal stimuli to assess both broadband (click) and tonal-specific hearing
frequencies. Three different age groups of mice were used: 3–4 weeks,
3 months and 6 months. In one case, 1-year-old mice were assessed.
A detailed description of the experimental procedures for ABR recordings
was previously described (Abitbol et al., 2016). Briefly, mice were deeply
anaesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine via
intraperitoneal injections. Supplemental half doses were administered as
necessary throughout the recordings. Electrical recordings of ABRs were
acquired through subdermal electrodes placed at the vertex (active
electrode), the mastoid of the right ear (reference electrode) and on the
mid-back (ground electrode). The body temperature of mice was maintained
at ∼37°C on a digital homeothermic heating pad throughout the experiment.
ABR thresholds were determined as the quietest sound stimulus that elicited
a peak in the ABRwaveform. For further analysis, BioSig software (Tucker-
Davis Technologies) was used to measure the amplitudes (which is the
number and synchrony of neurons firing) and latencies (which measures the
conductive speed of neurons) of the peak of the first wave of the ABR. These
auditory nerve measurements were elicited by the 90 dB SPL click stimulus
for all genotypes tested. All ABR waveform measurements were conducted
on raw ABR traces.
Organotypic cochlear cultures
Organotypic cochlear explant cultures were prepared from the cochleae of
postnatal day 1–3 mouse pups from a modified protocol previously
described (Mann et al., 2009). Briefly, pups were euthanized by decapitation
and the pup heads surface-sterilized in 80% ethanol for 10 min. The heads
were removed from the ethanol and placed in ice-cold Leibovitz’s L-15
medium (Thermo Fisher) where they were midsagitally bisected, brain
removed and cochlear bulla gently extracted. The cochlear capsule and
lateral wall were removed, leaving the organ of Corti and the greater
epithelial ridge attached to the modiolus. The organ of Corti was gently
peeled away from the modiolus and plated onto 14 mm diameter glass
MatTek dishes (MatTek Corporation) pre-coated with Cell-Tak (Corning)
diluted in 0.1 mM NaHCO3 to a final concentration of 70 µg/ml for
adhesion. Explants were immersed in DMEM/F12medium (Thermo Fisher)
supplemented with 5% FBS. Cultures were incubated at 37°C and 5% CO2
for 24 h and then fixed with 4% PFA for 20 min at room temperature.
Cultures were then blocked and permeabilized using 3% BSA+0.2% Triton
X-100 and incubated with mouse anti-Cx26 (1:300; Thermo Fisher,
33-5800) and/or rabbit anti-Cx30 (1:400; Thermo Fisher, 71-2200)
overnight at 4°C. Goat anti-mouse Alexa Fluor 488 and goat anti-rabbit
Alexa Fluor 633 (1:500; Thermo Fisher, A11001, A21070) were used to
visualize gap junctions, whilst an Alexa Fluor 555 phalloidin stain (1:400;
Thermo Fisher, A34055) was used to visualize hair cell stereocilia. Confocal
z-stacks and high-resolution Airyscan images were taken on an LSM800
confocal microscope (Zeiss) fitted with highly sensitive GaAsP detectors.
Images were taken at 1.0–1.3 µm increments with a 63×/1.40 NA oil
immersion lens either at 0.5× (confocal) or 1.3× (Airyscan) zoom. The full
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thickness of the tissue (from 35 to 61 µm for Fig. 3A) was imaged at
1.0–1.3 µm increments and flattened into a 2D image using ZEN Blue
software (Zeiss). Tissue thickness was kept to∼30 µm for images in Fig. 3B.
Cryosectioning and immunofluorescent labelling of cochleae
Following ABR recordings, mice were euthanized and cochleae were
dissected. A small incision was made in the cochlear bone near the apical
turn and 4% PFA was gently perfused through both the round and oval
windows of the cochleae, which were then bathed in 4% PFA overnight at
4°C and subsequently washed with PBS. Cochleae were decalcified in 4%
EDTA for ∼3 days and upon full decalcification were immersed in 30%
sucrose overnight for cryopreservation. Each cochlea was embedded in an
agarose solution, flash-frozen, and allowed to acclimate in a cryostat (Leica)
at −25°C. Sections were cut at 18 µm thickness and stored at −20°C until
use. Slides were blocked and permeabilized in 3% BSA+0.2% Triton X-100
solution. Subsequently, slides were incubated with primary antibodies
overnight at 4°C. These primary antibodies included rabbit anti-Cx30
(1:400; Thermo Fisher, 71-2200), rabbit anti-Kir4.1 (1:400; Alomone Labs,
APC-035), mouse anti-neurofilament (1:200; Sigma-Aldrich, N5389).
Slides were then washed and incubated with an appropriate fluorescently
conjugated Alexa Fluor secondary antibody (1:500; Thermo Fisher).
Subsequently, slides were stained with Hoechst to visualize nuclei.
Quantitative reverse-transcription polymerase chain reaction
Following euthanasia of mice by CO2, cochleae were dissected and
flash-frozen in liquid nitrogen. RNA was extracted from tissues using a
combination of Trizol (Thermo Fisher) and an RNeasy kit (Qiagen) as was
previously described (Abitbol et al., 2016). A Nanodrop spectrophotometer
was used to measure the absorbance of RNA, which was then converted to
cDNA using a SuperScript VILO cDNA synthesis kit (Thermo Fisher).
Quantitative polymerase chain reactions (qPCRs) were performed using a
SYBR Green PCR master mix (Thermo Fisher) in order to quantify mRNA
transcript expression of Cx26 and Cx30. The following primers were used:
Cx26-specific primers (forward, 5′-CCGTCTTCATGTACGTCTTTTAC-
AT-3′ and reverse, 5′-ATACCTAACGAACAAATAGCACAGC-3′) and
Cx30-specific primers (forward, 5′-GGCCGAGTTGTGTTACCTGCT-3′
and reverse, 5′-TCTCTTTCAGGGCATGGTTGG-3′). 18S ribosomal
ribonucleic acid (rRNA) was used as a housekeeping gene (forward, 5′-
GTAACCCGTTGAACCCCATT-3′ and reverse, 5′-CCATCCAATCGGT-
AGTAGCG-3′). The PCR thermal profile for all primers was as follows:
50°C for 2 min, 95°C for 2 min, 95°C for 5 s, 60°C for 15 s, followed by a
melt curve. Expression of transcripts were normalized to 18S rRNA for
quantification.
Protein extraction and immunoblotting
Following euthanasia of mice by CO2, cochleae were dissected, flash-frozen
in liquid nitrogen and either stored at −80°C or processed immediately.
Frozen cochleae were crushed with a mortar and pestle on dry ice with liquid
nitrogen, as we previously described (Abitbol et al., 2016). TRIzol (Thermo
Fisher) extraction was performed to separate RNA, DNA and protein
components of the tissue, as per manufacturer’s instructions. Protein was
isolated by using a series of wash steps including addition of phenol-
ethanol, wash solution consisting of 0.3 M guanidine hydrochloride in 95%
ethanol, and the protein pellet collected by centrifugation. The pellet was
then resuspended in 1% SDS+protease and phosphatase inhibitors, and
protein yield determined using the bicinchoninic acid (BCA) assay kit.
Equal amounts of protein (20 µg) were run on 10% polyacrylamide gels
using SDS-PAGE and transferred to nitrocellulose membranes using an
iBlot transfer apparatus (Thermo Fisher). Membranes were blocked with 3%
BSA in PBS-Tween (1× PBS, 0.05% Tween 20) for 1 h. Blots were then
probed at room-temperature for 2 h or overnight at 4°C with rabbit anti-
Cx30 (1:3000; Thermo Fisher, 71-2200), mouse anti-Cx26 (1:1000;
Thermo Fisher, 33-5800) and mouse anti-GAPDH (1:10,000; Chemicon,
MAB374) antibodies. Blots were washed and incubated for one hour with
goat anti-mouse Alexa Fluor 680 secondary antibody (1:10,000; Thermo
Fisher) for Cx26 and GAPDH, anti-rabbit IRdye 800CW (1:10,000; LI-
COR Biosciences, 926-32211) was used for Cx30. Membranes were
visualized with an Odyssey infrared imaging system (LI-COR). Quantitative
analysis was performed using Odyssey software (LI-COR) to assess the
amount of Cx30 and Cx26 protein. GAPDH was used as a loading control
and a reference protein for quantitative analysis.
Whole-mount dissection and immunofluorescence of adult
mouse cochlea
Following euthanasia of mice by CO2, temporal bones were dissected and
the cochleae were isolated. A small needlewas used to perforate a hole in the
apex of the cochlear bone and 4% PFA was gently perfused through the
round and oval windows. Cochleae were submersed in 4% PFA overnight at
4°C. After fixation, cochleae were rinsed in PBS and decalcified in 4%
EDTA for 3–4 days or until cochleae were fully decalcified. Whole-mount
dissections of adult cochlear turns were prepared as follows. Firstly, a piece
of a razor blade was used to bisect the cochlea. Tissue connections,
Reissner’s membrane and tectorial membrane were then peeled away with
#55 fine forceps (Fisher Scientific). Razor blade pieces in a blade holder
were used to dissect away lateral wall and excess spiral ganglion tissue to
leave approximately six segments of the cochlear epithelium from base
to apex. Whole-mount sections were blocked and permeabilized with 3%
BSA+0.2% Triton X-100 for one hour. Various primary antibodies were
incubated overnight at 4°C including rabbit anti-myosin-VI (1:200; Proteus
Biosciences, 25-6791), and rabbit anti-Cx30 (1:400; Thermo Fisher,
71-2200). Alexa Fluor secondary antibodies (Thermo Fisher) were used
as well as a phalloidin-conjugated stain to visualize hair cell stereocilia as
described above in organotypic cochlear cultures. Finally, Hoechst 33342
was used to label nuclei and whole-mount cochleae were mounted and
imaged on an LSM800 confocal microscope.
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